{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:21:16Z","timestamp":1790979676387,"version":"4.1.0"},"reference-count":51,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.3892\/or.2013.2309","type":"journal-article","created":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T08:48:33Z","timestamp":1361954913000},"page":"1819-1826","source":"Crossref","is-referenced-by-count":33,"title":["Genome-wide analysis of DNA methylation in tongue squamous cell carcinoma"],"prefix":"10.3892","volume":"29","author":[{"given":"SHENG","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIANG-LING","family":"FENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LEI","family":"SHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHAO-JIAN","family":"GONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHI-JING","family":"HE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAN-JIANG","family":"WU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TIAN-YOU","family":"LING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,2,27]]},"reference":[{"key":"key20180107214323_b1-or-29-05-1819","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/1874210601206010126","article-title":"Current aspects on oral squamous cell carcinoma","volume":"6","author":"Markopoulos","year":"2012","journal-title":"Open Dent J"},{"key":"key20180107214323_b2-or-29-05-1819","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180107214323_b3-or-29-05-1819","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/154405910808700104","article-title":"Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy","volume":"87","author":"Choi","year":"2008","journal-title":"J Dent Res"},{"key":"key20180107214323_b4-or-29-05-1819","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s13148-011-0045-3","article-title":"Role of DNA methylation in head and neck cancer","volume":"2","author":"Demokan","year":"2011","journal-title":"Clin Epigenetics"},{"key":"key20180107214323_b5-or-29-05-1819","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1601-0825.2011.01833.x","article-title":"DNA methylation in oral squamous cell carcinoma: molecular mechanisms and clinical implications","volume":"17","author":"Gonz\u00e1lez-Ram\u00edrez","year":"2011","journal-title":"Oral Dis"},{"key":"key20180107214323_b6-or-29-05-1819","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature08514","article-title":"Human DNA methylomes at base resolution show widespread epigenomic differences","volume":"462","author":"Lister","year":"2009","journal-title":"Nature"},{"key":"key20180107214323_b7-or-29-05-1819","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/ng1598","article-title":"Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells","volume":"37","author":"Weber","year":"2005","journal-title":"Nat Genet"},{"key":"key20180107214323_b8-or-29-05-1819","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","article-title":"DNA methylation patterns and epigenetic memory","volume":"16","author":"Bird","year":"2002","journal-title":"Genes Dev"},{"key":"key20180107214323_b9-or-29-05-1819","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1756-8935-5-9","article-title":"Genome-wide DNA methylation profiling of non-small cell lung carcinomas","volume":"5","author":"Carvalho","year":"2012","journal-title":"Epigenetics Chromatin"},{"key":"key20180107214323_b10-or-29-05-1819","first-page":"939","article-title":"Promoter hypermethylation patterns of p16, O6-methylguanine-DNAmethyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients","volume":"61","author":"Rosas","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107214323_b11-or-29-05-1819","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2144\/000112708","article-title":"Methyl-DNA immunoprecipitation (MeDIP): hunting down the DNA methylome","volume":"44","author":"Jacinto","year":"2008","journal-title":"Biotechniques"},{"key":"key20180107214323_b12-or-29-05-1819","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N Engl J Med"},{"key":"key20180107214323_b13-or-29-05-1819","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000474455","article-title":"Abnormal c-myc oncogene DNA methylation in human bladder cancer: possible role in tumor progression","volume":"31","author":"Sardi","year":"1997","journal-title":"Eur Urol"},{"key":"key20180107214323_b14-or-29-05-1819","first-page":"5295","article-title":"Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia","volume":"62","author":"Kresty","year":"2002","journal-title":"Cancer Res"},{"key":"key20180107214323_b15-or-29-05-1819","first-page":"5954","article-title":"Predicting lung cancer by detecting aberrant promoter methylation in sputum","volume":"60","author":"Palmisano","year":"2000","journal-title":"Cancer Res"},{"key":"key20180107214323_b16-or-29-05-1819","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/sj.bjc.6604760","article-title":"Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer","volume":"99","author":"Cheng","year":"2008","journal-title":"Br J Cancer"},{"key":"key20180107214323_b17-or-29-05-1819","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/sj.onc.1207323","article-title":"Immunological and pathobiological roles of fibulin-1 in breast cancer","volume":"23","author":"Pupa","year":"2004","journal-title":"Oncogene"},{"key":"key20180107214323_b18-or-29-05-1819","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/pros.20667","article-title":"Downregulation of several fibulin genes in prostate cancer","volume":"67","author":"Wlazlinski","year":"2007","journal-title":"Prostate"},{"key":"key20180107214323_b19-or-29-05-1819","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/mc.20735","article-title":"Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma","volume":"50","author":"Kanda","year":"2011","journal-title":"Mol Carcinog"},{"key":"key20180107214323_b20-or-29-05-1819","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1242\/jcs.114.24.4587","article-title":"Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility","volume":"114","author":"Twal","year":"2001","journal-title":"J Cell Sci"},{"key":"key20180107214323_b21-or-29-05-1819","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.onc.1210669","article-title":"The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation","volume":"27","author":"Veeck","year":"2008","journal-title":"Oncogene"},{"key":"key20180107214323_b22-or-29-05-1819","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2003.09.011","article-title":"ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer","volume":"204","author":"Himmelfarb","year":"2004","journal-title":"Cancer Lett"},{"key":"key20180107214323_b23-or-29-05-1819","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2407-8-25","article-title":"Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis","volume":"8","author":"Hamm","year":"2008","journal-title":"BMC Cancer"},{"key":"key20180107214323_b24-or-29-05-1819","doi-asserted-by":"crossref","first-page":"e5892","DOI":"10.1371\/journal.pone.0005892","article-title":"RUNX3 has an oncogenic role in head and neck cancer","volume":"4","author":"Tsunematsu","year":"2009","journal-title":"PLoS One"},{"key":"key20180107214323_b25-or-29-05-1819","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0092-8674(02)00690-6","article-title":"Causal relationship between the loss of RUNX3 expression and gastric cancer","volume":"109","author":"Li","year":"2002","journal-title":"Cell"},{"key":"key20180107214323_b26-or-29-05-1819","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1158\/0008-5472.CAN-05-0743","article-title":"RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization","volume":"65","author":"Ito","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107214323_b27-or-29-05-1819","doi-asserted-by":"crossref","first-page":"9347","DOI":"10.1158\/0008-5472.CAN-05-1647","article-title":"RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors","volume":"65","author":"Kim","year":"2002","journal-title":"Cancer Res"},{"key":"key20180107214323_b28-or-29-05-1819","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1440-1746.2009.06191.x","article-title":"Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer","volume":"25","author":"Chen","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"key20180107214323_b29-or-29-05-1819","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1478-3231.2005.1059.x","article-title":"Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma","volume":"5","author":"Mori","year":"2005","journal-title":"Liver Int"},{"key":"key20180107214323_b30-or-29-05-1819","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/jcb.22973","article-title":"Loss of runt-related transcription factor 3 causes development and progression of hepatocellular carcinoma","volume":"112","author":"Shiraha","year":"2011","journal-title":"J Cell Biochem"},{"key":"key20180107214323_b31-or-29-05-1819","first-page":"523","article-title":"Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling","volume":"26","author":"Nishina","year":"2011","journal-title":"Oncol Rep"},{"key":"key20180107214323_b32-or-29-05-1819","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.1038\/sj.onc.1207731","article-title":"Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines","volume":"23","author":"Ku","year":"2004","journal-title":"Oncogene"},{"key":"key20180107214323_b33-or-29-05-1819","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1158\/0008-5472.CAN-09-3805","article-title":"Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer","volume":"70","author":"Lee","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107214323_b34-or-29-05-1819","first-page":"817","article-title":"Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines","volume":"14","author":"Yanada","year":"2005","journal-title":"Oncol Rep"},{"key":"key20180107214323_b35-or-29-05-1819","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/0008-5472.CAN-03-2144","article-title":"Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck","volume":"64","author":"Ginos","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107214323_b36-or-29-05-1819","doi-asserted-by":"crossref","first-page":"7646","DOI":"10.1038\/sj.onc.1209739","article-title":"RUNX3 protein is overexpressed in human basal cell carcinomas","volume":"25","author":"Salto-Tellez","year":"2006","journal-title":"Oncogene"},{"key":"key20180107214323_b37-or-29-05-1819","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ygyno.2011.04.044","article-title":"RUNX3 functions as an oncogene in ovarian cancer","volume":"122","author":"Lee","year":"2011","journal-title":"Gynecol Oncol"},{"key":"key20180107214323_b38-or-29-05-1819","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/jcb.22967","article-title":"Oncogenic role of RUNX3 in head and neck cancer","volume":"112","author":"Kudo","year":"2011","journal-title":"J Cell Biochem"},{"key":"key20180107214323_b39-or-29-05-1819","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/jcb.23047","article-title":"RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers","volume":"112","author":"Ito","year":"2011","journal-title":"J Cell Biochem"},{"key":"key20180107214323_b40-or-29-05-1819","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1158\/0008-5472.CAN-06-0369","article-title":"RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer","volume":"66","author":"Lau","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107214323_b41-or-29-05-1819","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1074\/jbc.M005889200","article-title":"Bcl-G, a novel pro-apoptotic member of the Bcl-2 family","volume":"276","author":"Guo","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180107214323_b42-or-29-05-1819","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/pros.21186","article-title":"Apoptosis regulators Fau and Bcl-G are down-regulated in prostate cancer","volume":"70","author":"Pickard","year":"2010","journal-title":"Prostate"},{"key":"key20180107214323_b43-or-29-05-1819","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/bcr2350","article-title":"Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer","volume":"11","author":"Pickard","year":"2009","journal-title":"Breast Cancer Res"},{"key":"key20180107214323_b44-or-29-05-1819","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1349-7006.2008.01066.x","article-title":"Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung","volume":"100","author":"Ikeda","year":"2009","journal-title":"Cancer Sci"},{"key":"key20180107214323_b45-or-29-05-1819","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.febslet.2007.02.025","article-title":"Expression of the CUB domain containing protein 1 (CDCP1) gene in colorectal tumour cells","volume":"581","author":"Perry","year":"2007","journal-title":"FEBS Lett"},{"key":"key20180107214323_b46-or-29-05-1819","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/path.2026","article-title":"Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells","volume":"210","author":"Ikeda","year":"2006","journal-title":"J Pathol"},{"key":"key20180107214323_b47-or-29-05-1819","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbrc.2011.09.062","article-title":"Effect of the tyrosine kinase inhibitor lapatinib on CUB-domain containing protein (CDCP1)-mediated breast cancer cell survival and migration","volume":"414","author":"Seidel","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107214323_b48-or-29-05-1819","first-page":"4174","article-title":"Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers","volume":"63","author":"Yuan","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107214323_b49-or-29-05-1819","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1073\/pnas.96.1.214","article-title":"NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas","volume":"96","author":"Yu","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107214323_b50-or-29-05-1819","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1038\/sj.onc.1206380","article-title":"ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers","volume":"22","author":"Luo","year":"2003","journal-title":"Oncogene"},{"key":"key20180107214323_b51-or-29-05-1819","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/mc.20461","article-title":"ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis","volume":"48","author":"Huang","year":"2009","journal-title":"Mol Carcinog"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2013.2309\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T15:13:52Z","timestamp":1644419632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2013.2309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,27]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,2,27]]},"published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.3892\/or.2013.2309"],"URL":"https:\/\/doi.org\/10.3892\/or.2013.2309","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,27]]}}}